Danaher Corporation (DHR)

NYSE · Healthcare · Diagnostics & Research
$220.36-3.16%As of 2026-11-22 · USD
Last session low $219.93Last session high $228.10
52-week low $160.9352-week high $242.80
Market cap
$155.03B
Sector
Healthcare
P/E (TTM)
36.5x
Dividend yield
0.73%
Next earnings
2027-01-27 (est.)

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)43.6In the neutral range (30 to 70)
MACD (12, 26, 9)0.54Below its signal line (2.01); histogram -1.48
Bollinger %B (20, 2)-24%Below the lower band (223.85 to 238.61)
SMA 20231.23Price is 4.7% below
SMA 50224.84Price is 2.0% below
SMA 200200.94Price is 9.7% above
ATR (20)2.79% of priceAverage true range per day
52-week position73%In the upper part of the 160.93 to 242.80 range

About Danaher Corporation

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments.

Latest fiscal yearEnded 2025-12-31: revenue of $24.57B and an operating margin of 19.1%.
Next earnings reportExpected on 2027-01-27 (the date is an estimate).

More in Diagnostics & Research